Randy Riggs

Randy Riggs has over 25 years of experience in the biopharmaceutical industry. Randy began their career in 1992 as a Manager of Corporate Development at Eli Lilly & Company. In 1998, they joined Lexicon Genetics as the Senior Vice President of Corporate Development, where they developed business revenue and self-sustaining drug discovery strategies. In 2005, they moved to BioCryst Pharmaceuticals, Inc. as the Senior Vice President of Corporate Development, where they negotiated and completed several major business partnering transactions. In 2007, they became the President & CEO of Advanced Cancer Therapeutics (ACT). In 2018, they joined Amytrx Therapeutics, Inc. as the Chief Business Officer and Gibson Oncology, LLC as the President & CEO.

Randy Riggs obtained a Bachelor's Degree in Management and Economics from Texas A&M University from 1986 to 1989. Randy then went on to obtain an MBA in Finance from the University of Houston from 1992 to 1995.